By Adriano Marchese
Trulieve Cannabis received regulatory approval to list its shares on the New York Stock Exchange, becoming the first cannabis company cleared to trade on a major U.S. stock exchange.
The medical cannabis company, which is currently listed on the Canadian Securities Exchange, on Friday said that the move was possible thanks to the reclassification of medical marijuana to Schedule III in April.
Trulieve said that the final order rescheduled state licensed medical cannabis products and created a pathway for Drug Enforcement Administration registration for state licensed medical marijuana businesses.
To take advantage of the new schedule, Trulieve completed a restructuring plan and investment by a third party which deconsolidated operations in markets serving both medical and adult use customers. Following the restructuring, its operations now include only state-licensed medical marijuana facilities with 206 dispensaries and 3.5 million square feet of DEA-registered production capacity.
The company expects its subordinate voting shares will begin trading on the NYSE under the ticker symbol TRLV beginning on June 10.
"As the first U.S. cannabis company to list on a major U.S. exchange, we are excited for the opportunity to expand our shareholder base, increase liquidity, and raise awareness for the benefits of medical marijuana," founder and Chief Executive Kim Rivers said.
Write to Adriano Marchese at adriano.marchese@wsj.com
(END) Dow Jones Newswires
June 05, 2026 07:50 ET (11:50 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.